By Deena Beasley Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite ...

The FDA typically follows the recommendations of its advisory panels but is not required to do so. If cleared for use, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Developed in partnership with agency Wieden+Kennedy Portland, Lilly’s Good Days officially launched on Sunday. The spot will air in the final slot before showings of Wicked: For Good and during the ...

Officials say the pact, facilitated by the Indianapolis-based IU Launch Accelerator for Biosciences, is the largest single ...

Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and ...

Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here ...

It's Alzheimer's Awareness month and navigating cognitive health conversations can be difficult. Actress, Julianne Moore partnered with Eli Lilly for their 'Brain Health Matters' Campaign and told us ...

Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, ...

Eli Lilly is continuing its recent pattern of tying disease awareness-raising efforts to major pop cultural moments. The latest high-profile crossovers—which include a starry TV partnership and the ...

INDIANAPOLIS — Indiana University and pharmaceutical giant Eli Lilly have made official a five-year collaboration in which ...

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...